Hiroshi Imoto
Impact in
- Virology top 10%
- HIV Research and Treatment
- Organic Chemistry top 10%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
Papers in
-
- Peroxisome Proliferator-Activated Receptors 4
- Cancer therapeutics and mechanisms 2
- Metabolism, Diabetes, and Cancer 2
-
- Asymmetric Synthesis and Catalysis 4
- Fullerene Chemistry and Applications 2
- Co-authors
- Keiji Maruoka (6 shared papers)Hisashi Yamamoto (6 shared papers)Koji Sekai (2 shared papers)Hideto Azuma (1 shared paper)Thomas J. Wandless (2 shared papers)Susumu Saito (2 shared papers)Mitsuru Shiraishi (2 shared papers)Masaki Seto (2 shared papers)
- Journals
- Chemical and Pharmaceutical Bulletin (4 papers)Synlett (4 papers)Journal of the American Chemical Society (3 papers)Journal of Medicinal Chemistry (2 papers)Journal of Power Sources (2 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Hiroshi Imoto
25 papers receiving 722 citations
Peers
Comparison fields: 5 of 94
- Virology 62
- Organic Chemistry 302
- Molecular Biology 246
- Oncology 87
- Pharmaceutical Science 19
Countries citing papers authored by Hiroshi Imoto
This map shows the geographic impact of Hiroshi Imoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Imoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Imoto more than expected).
Fields of papers citing papers by Hiroshi Imoto
This network shows the impact of papers produced by Hiroshi Imoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Imoto. The network helps show where Hiroshi Imoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Imoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 152 | |
| 2 | 1999 | 92 | |
| 3 | 1994 | 77 | |
| 4 | 2012 | 69 | |
| 5 | 1994 | 65 | |
| 6 | 2012 | 62 | |
| 7 | 2013 | 33 | |
| 8 | 2004 | 31 | |
| 9 | 2014 | 25 | |
| 10 | 1994 | 24 | |
| 11 | 2019 | 18 | |
| 12 | 2003 | 18 | |
| 13 | 2004 | 15 | |
| 14 | 2002 | 14 | |
| 15 | 1994 | 10 | |
| 16 | 2001 | 9 | |
| 17 | 2004 | 8 | |
| 18 | 1994 | 8 | |
| 19 | 1994 | 6 | |
| 20 | 1994 | 5 |
About Hiroshi Imoto
Hiroshi Imoto is a scholar working on Molecular Biology, Organic Chemistry, Biochemistry, Pharmaceutical Science and Oncology, having authored 25 papers that have together received 753 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Asymmetric Synthesis and Catalysis (4 papers), Advancements in Battery Materials (3 papers), Advanced NMR Techniques and Applications (2 papers), HIV Research and Treatment (2 papers), Cancer therapeutics and mechanisms (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Fullerene Chemistry and Applications (2 papers). The work is most often cited by research in Virology (62 citations), Organic Chemistry (302 citations), Molecular Biology (246 citations), Oncology (87 citations) and Pharmaceutical Science (19 citations). Hiroshi Imoto has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Keiji Maruoka, Hisashi Yamamoto, Koji Sekai, Hideto Azuma, Thomas J. Wandless, Susumu Saito, Mitsuru Shiraishi, Masaki Seto, Masanori Baba and Yusuke Miyazaki. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, Synlett, Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Power Sources.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.